Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• The Future of Drug Safety: Promoting and Protecting the Health of the Public (ISBN ) Committee on the Assessment of the US Drug Safety System, Alina Baciu, Kathleen Stratton, Sheila P. Burke, Editors


• Ethical and Scientific Issues in Studying the Safety of Approved Drugs (ISBN ) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• Challenges for the FDA: The Future of Drug Safety, Workshop Summary (ISBN ) Leslie Pray and Sally Robinson, Rapporteurs, Forum on Drug Discovery, Development, and Translation


• Building a National Framework for the Establishment of Regulatory Science for Drug Development:Workshop Summary (ISBN ) Yeonwoo Lebovitz, Rebecca English, and Anne Claiborne; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• The Safe Use Initiative and Health Literacy: Workshop Summary (ISBN ) Cori Vancheri, Rapporteur; Roundtable on Health Literacy; Institute of Medicine


• Preventing Medication Errors: Quality Chasm Series (ISBN ) Committee on Identifying and Preventing Medication Errors, Philip Aspden, Julie Wolcott, J. Lyle Bootman, Linda R. Cronenwett, Editors


• Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (ISBN ) Christine M. Micheel and John R. Ball, Editors; Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine


• Assessing and Improving Value in Cancer Care:Workshop Summary (ISBN ) Adam Schickedanz, Rapporteur; Institute of Medicine


• Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act (ISBN ) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Institute of Medicine


• Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary (ISBN ) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine


• Scientific Standards for Studies on Modified Risk Tobacco Products (ISBN ) Committee on Scientific Standards for Studies on Modified Risk Tobacco Products; Institute of Medicine


• Rare Diseases and Orphan Products: Accelerating Research and Development (ISBN ) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine


• Leadership Commitments to Improve Value in Health Care:Finding Common Ground: Workshop Summary (ISBN ) LeighAnne Olsen, W. Alexander Goolsby, and J. Michael McGinnis; Roundtable on Evidence-Based Medicine


• Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: Workshop Summary (ISBN ) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Accelerating the Development of Biomarkers for Drug Safety:Workshop Summary (ISBN ) Steve Olson, Sally Robinson, and Robert Giffin, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Food and Drug Administration Advisory Committees (ISBN ) Richard A. Rettig, Laurence E. Earley, and Richard A. Merrill, Editors; Committee to Study the Use of Advisory Committees, Institute of Medicine


• Standardizing Medication Labels:Confusing Patients Less, Workshop Summary (ISBN ) Lyla M. Hernandez, Rapporteur, Roundtable on Health Literacy


• Policy Issues in the Development of Personalized Medicine in Oncology:Workshop Summary (ISBN ) Margie Patlak and Laura Levit, Rapporteurs; Institute of Medicine


• Improving the Quality of Cancer Clinical Trials:Workshop Summary (ISBN ) Margie Patlak and Sharyl Nass, Rapporteurs


• Expanding Access to Investigational Therapies for HIV Infection and AIDS (ISBN ) Roundtable for the Development of Drugs and Vaccines Against AIDS, Institute of Medicine


• Safe Medical Devices for Children (ISBN ) Marilyn J. Field and Hugh Tilson, Editors, Committee on Postmarket Surveillance of Pediatric Medical Devices


• Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary (ISBN ) Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Forum on Medical and Public Health Preparedness for Catastrophic Events; Institute of Medicine


• Breakthrough Business Models:Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary (ISBN ) Theresa Wizeman, Sally Robinson, and Robert Giffin, Forum on Drug Discovery, Development, and Translation, Institute of Medicine


• Addressing the Barriers to Pediatric Drug Development: Workshop Summary (ISBN ) Cori Vanchieri, Adrienne Stith Butler, and Andrea Knutsen, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad (ISBN ) Jim E. Riviere and Gillian J. Buckley, Editors; Committee on Strengthening Core Elements of Regulatory Systems in Developing Countries; Board on Global Health; Board on Health Sciences Policy; Institute of Medicine


• Perspectives on Essential Health Benefits:Workshop Report (ISBN ) Cheryl Ulmer, Bernadette McFadden, and Cassandra Cacace, Rapporteurs; Committee on Defining and Revising an Essential Health Benefits Package for Qualified Health Plans; Institute of Medicine


• Informing the Future: Critical Issues in Health, Fourth Edition (ISBN )


• The National Cancer Policy Summit: Opportunities and Challenges in Cancer Research and Care: Workshop Summary (ISBN ) Margie Patlak, Sharyl J. Nass, and Erin Balogh, Rapporteurs; National Cancer Policy Forum; Institute of Medicine


• A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration (ISBN ) Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II; National Research Council


• Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation: Workshop Report (ISBN ) Theresa Wizemann, Editor; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• Biomedical Politics (ISBN ) Kathi E. Hanna, Editor; Committee to Study Decision Making, Division of Health Sciences Policy


• The Changing Economics of Medical Technology (ISBN ) Annetine C. Gelijns and Ethan A. Halm, Editors; Committee on Technological Innovation in Medicine, Institute of Medicine


• Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment: The State of the Science, Evaluation, Implementation, and Economics ? Workshop Summary (ISBN ) Margie Patlak and Sharyl Nass, Rapporteurs


• Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years (ISBN ) Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• Animal Models for Assessing Countermeasures to Bioterrorism Agents (ISBN ) Committee on Animal Models for Assessing Countermeasures to Bioterrorism Agents; National Research Council


• Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary (ISBN ) Victoria Weisfeld, Rebecca A. English, Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• The Social Impact of AIDS in the United States (ISBN ) Panel on Monitoring the Social Impact of the AIDS Epidemic, National Research Council


• Public Health Effectiveness of the FDA 510(k) Clearance Process: Measuring Postmarket Performance and Other Select Topics: Workshop Report (ISBN ) Theresa Wizemann, Editor; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• Technology and Health Care in an Era of Limits (ISBN ) Annetine C. Gelijns, Editor; Committee on Technology Innovation in Medicine, Institute of Medicine


• Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment (ISBN ) Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment, Sharyl J. Nass and Harold L. Moses, Editors


• The Development of Medications for the Treatment of Opiate and Cocaine Addictions:Issues for the Government and Private Sector (ISBN ) Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, Editors; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Institute of Medicine


• Genome-Based Therapeutics:Targeted Drug Discovery and Development: Workshop Summary (ISBN ) Adam C. Berger and Steve Olson, Rapporteurs; Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine


• Product Liability and Innovation:Managing Risk in an Uncertain Environment (ISBN ) Janet R. Hunziker and Trevor O. Jones, Editors; Steering Committee on Product Liability and Innovation; National Academy of Engineering


• Facilitating Collaborations to Develop Combination Investigational Cancer Therapies: Workshop Summary (ISBN ) Margie Patlak, Erin Balogh, and Sharyl J. Nass, Rapporteurs; National Cancer Policy Forum; Institute of Medicine


• Ethical Issues in Studying the Safety of Approved Drugs:A Letter Report (ISBN ) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• Perspectives on Biomarker and Surrogate Endpoint Evaluation:Discussion Forum Summary (ISBN ) Alison Mack, Erin Balogh, and Christine Micheel, Rapporteurs; Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine


• Transforming Clinical Research in the United States:Challenges and Opportunities: Workshop Summary (ISBN ) Rebecca English, Yeonwoo Lebovitz, and Robert Griffin, authors; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Assuring Data Quality and Validity in Clinical Trials for Regulatory Decision Making:Workshop Report (ISBN ) Jonathan R. Davis, Vivian P. Nolan, Janet Woodcock, and Ronald W. Estabrook, Editors; Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Institute of Medicine


• Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary (ISBN ) Margie Patlak, Sharyl Nass, and Christine Micheel, Rapporteurs, Institute of Medicine


• Emerging Safety Science: Workshop Summary (ISBN ) Sally Robinson, Robert Pool, and Robert Giffin, Forum on Drug Discovery, Development, and Translation, Institute of Medicine